ライフサイエンスコーパス: right heart catheterization

1 g hemodynamics underwent subsequent exercise right heart catheterization.

2 who were referred for a clinically indicated right heart catheterization.

3 thered data on IPAH patients who underwent a right heart catheterization.

4 -time MRI (MR fluoroscopy) to guide left and right heart catheterization.

5 PCWP was measured with right heart catheterization.

6 tients with pulmonary hypertension underwent right heart catheterization.

7 ameters, transthoracic echocardiography, and right heart catheterization.

8 based on pre-LVAD hemodynamics obtained via right heart catheterization.

9 regurgitation velocity 2.5 m/s proceeded to right heart catheterization.

10 mal exercise (25 W), and peak exercise using right heart catheterization.

11 tients with PH-HFpEF obtained at the time of right heart catheterization.

12 ted by echocardiography and were obtained by right heart catheterization.

13 was obtained simultaneously with direct Fick right heart catheterization.

14 atients underwent additional exercise stress right heart catheterization.

15 uspected of pulmonary hypertension underwent right heart catheterization.

16 fied as HFpEF or noncardiac dyspnea based on right heart catheterization.

17 ress (PCWP >= 25 mm Hg, n = 13) according to right heart catheterization.

18 tomography scans performed within 2 days of right heart catheterization.

19 AH using Optical Coherence Tomography during Right Heart catheterization.

20 nits; or (3) inpatient status at the time of right heart catheterization.

21 ients with unexplained dyspnea who underwent right heart catheterization.

22 s bag technique in adult patients undergoing right heart catheterization.

23 sure >35 mm Hg on echocardiogram underwent a right heart catheterization.

24 terminal telopeptide of type I collagen) and right heart catheterization.

25 anently implanted in all participants during right heart catheterization.

26 iratory rise in right atrial pressure during right heart catheterization.

27 onse to vasodilator testing require invasive right heart catheterization.

28 ange; P <.05) in the 6 patients restudied by right-heart catheterization.

29 Pulmonary hypertension was determined by right-heart catheterization.

30 revalence of up to 78% in those referred for right-heart catheterization.

31 ertension, but definitive diagnosis requires right-heart catheterization.

32 ss hemodynamic variables were measured using right-heart catheterization.

33 ly evaluated with serial echocardiograms and right heart catheterizations.

34 d retrospectively all US veterans undergoing right heart catheterization (2007-2012) in the Veterans

35 In patients with right heart catheterization (30 HF-PH, 14 PVOD), similar

36 Patients were classified by right heart catheterization according to current guideli

37 of cardiologists were more likely to undergo right-heart catheterization (adjusted odds ratio, 2.9 [C

38 alysis included outcomes among patients with right heart catheterization after the first echocardiogr

39 Hemodynamic values from right heart catheterization aid diagnosis and clinical d

40 nary capillary wedge pressure </=15 mm Hg at right heart catheterization (allele frequency, 0.66; odd

41 nsplant patients, five of which had multiple right heart catheterizations allowing an assessment of c

42 es are not universally detectable by resting right heart catheterization alone and call for further s

43 To define LV pressure-volume relationships, right heart catheterization and 3-dimensional echocardio

44 nts known or suspected to have PAH underwent right heart catheterization and adenosine stress MR imag

45 Patients underwent right heart catheterization and cardiac magnetic resonan

46 ents with pulmonary arterial hypertension by right heart catheterization and cardiac magnetic resonan

47 consent, 35 PAH patients were evaluated with right heart catheterization and cardiac magnetic resonan

48 In vivo measurements were assessed using right heart catheterization and cardiac MRI.

49 patients underwent rest and exercise-stress right heart catheterization and cardiovascular magnetic

50 Patients referred to both right heart catheterization and cardiovascular magnetic

51 ved from 60 COPD patients who underwent both right heart catheterization and computed tomography in a

52 spectively evaluated 53 PPH patients who had right heart catheterization and cycle ergometer CPET stu

53 onsecutive patients, undergoing simultaneous right heart catheterization and DE.

54 mptoms of congestive heart failure underwent right heart catheterization and Doppler-echocardiography

55 consecutive participants who underwent both right heart catheterization and dual-phase dual-energy C

56 -17 years, 19 women) undergoing simultaneous right heart catheterization and echocardiographic imagin

57 In 50 patients with simultaneous right heart catheterization and echocardiographic imagin

58 Nine of the 16 patients underwent right heart catheterization and echocardiography during

59 II; Thoratec Inc; n=18) were evaluated with right heart catheterization and echocardiography preoper

60 Right heart catheterization and echocardiography were pe

61 upine cycle ergometer test with simultaneous right heart catheterization and echocardiography.

62 able patients who underwent first diagnostic right heart catheterization and from a prospective cohor

63 ly assessed with invasive procedures such as right heart catheterization and histopathology.

64 CMR) imaging within 24 hours of a diagnostic right heart catheterization and invasive measurement of

65 utinely underwent detailed reassessment with right heart catheterization and noninvasive testing at 3

66 All measurements, including data from right heart catheterization and norepinephrine requireme

67 nts undergoing clinically indicated left and right heart catheterization and same day research cardia

68 pulmonary edema, invasive techniques such as right heart catheterization and the sampling of alveolar

69 Hemodynamic variables obtained by right heart catheterization and transpulmonary thermodil

70 modynamic evaluation was performed by serial right heart catheterization and transthoracic echocardio

71 omboembolic pulmonary hypertension underwent right heart catheterization and-after digital subtractio

72 Right-heart catheterization and echocardiography were pe

73 weeks after therapy; patients also underwent right-heart catheterization and LSM at these time points

74 ventricular pressure-volume loop recordings, right heart catheterization, and arterial and mixed veno

75 spectively enrolled with follow-up clinical, right heart catheterization, and echocardiographic evalu

76 ents who had coronary physiology assessment, right heart catheterization, and echocardiography perfor

77 not demonstrated any sustained benefits from right heart catheterization, and some studies have even

78 erization," "Swan-Ganz catheterization" and "right heart catheterization," and restricting the result

79 A Supright exercise right heart catheterization approach is feasible and mer

80 isk factors using systematic confirmation on right heart catheterization are lacking.

81 Echocardiography and right heart catheterization are the principal modalities

82 diac studies, including echocardiography and right heart catheterization, are key elements in the ass

83 ntricular ejection fraction <=45% undergoing right heart catheterization as part of advanced heart fa

84 sure product was also determined by means of right heart catheterization, as an index of the RV MVO2,

85 s with PAH (81% idiopathic) with a follow-up right heart catheterization at 6 months (interquartile r

86 All patients underwent right heart catheterization at baseline and were followe

87 Patients underwent right heart catheterization at rest and during exercise

88 underwent simultaneous echocardiography and right heart catheterization at rest and during exercise.

89 asymptomatic, severe AS were evaluated with right heart catheterization at rest and during moderate

90 0 years; n=14 HFpEF; n=12 control) underwent right heart catheterization at rest, during supine exerc

91 cular ejection fraction <=45%) who underwent right heart catheterization at The Department of Cardiol

92 rimetry in 43 patients with HFpEF undergoing right heart catheterization at the University of Michiga

93 as demonstrated by pulmonary hypertension at right-heart catheterization at days 21 to 35 and major r

94 Patients underwent right-heart catheterization at rest and during exercise

95 ce on the basis of PC-MRI in comparison with right heart catheterization-based measurements by a medi

96 Twenty-six patients underwent preoperative right heart catheterization before PTE.

97 d vital status for all patients referred for right heart catheterization between 1998 and 2014.

98 ve patients with heart failure who underwent right heart catheterization between 2000 and 2005.

99 We examined consecutive patients undergoing right heart catheterization between 2005 and 2016 in a h

100 We examined patients undergoing right heart catheterization between 2005 and 2016 in a h

101 Using the index right heart catheterization between 2010 and 2016, we ca

102 increased mean pulmonary artery pressure (on right heart catheterization), by 0.27 mm Hg (0.27; 95% C

103 operation [n=6]) were evaluated monthly with right heart catheterization, CMR, and computed tomograph

104 scovery cohort and a sex-balanced validation right heart catheterization cohort from Vanderbilt Unive

105 two cohorts based on the date of diagnostic right heart catheterization: cohort A included patients

106 Right heart catheterization confirmed constrictive physi

107 Also, right heart catheterization confirmed higher right atria

108 Patients were stratified by current resting right heart catheterization criteria, and in a separate

109 Laboratory, echocardiography, and right heart catheterization data collected from 205 pati

110 Right heart catheterization data from clinical records o

111 distress syndrome who had complete baseline right heart catheterization data from the Fluid and Cath

112 h heart failure, we retrospectively assessed right heart catheterization data in 162 consecutive pati

113 Peak VO2 outperforms clinical variables, right-heart catheterization data, exercise time, and oth

114 oups of PH and is hemodynamically defined by right heart catheterization demonstrating a mean pulmona

115 e data regarding the utility of preoperative right heart catheterization-derived parameters in patien

116 Right heart catheterization-derived parameters offer ins

117 nship between screening echocardiography and right heart catheterization determinations of pressure,

118 om 1998 to 2016 from a single center and had right heart catheterizations during the procedure.

119 apillary wedge pressure waveform obtained by right-heart catheterization during 5 different loading c

120 utine invasive hemodynamic ramp testing with right heart catheterization, during which LVAD speeds we

121 ach treatment period, participants underwent right heart catheterization, echocardiography, and blood

122 of each treatment period, patients underwent right heart catheterization, echocardiography, and blood

123 Right heart catheterization evaluated hemodynamics.

124 HA) class III or IV symptomatology underwent right heart catheterization for determination of baselin

125 Patients undergoing right heart catheterization for evaluation of pulmonary

126 udy enrolling patients referred for exercise right heart catheterization for HFpEF.

127 Of 3702 patients undergoing right heart catheterization for PAH diagnosis, 2051 had

128 inferior vena cava and hepatic veins during right heart catheterization from 3 groups of patients: (

129 al fibrillation included corticosteroid use, right heart catheterization, fungal infection, vasopress

130 dopamine-derived radioactivity who underwent right-heart catheterization had a decreased cardiac extr

131 ographic techniques for the determination of right heart catheterization hemodynamic variables in pat

132 Patients underwent right heart catheterization immediately followed by tran

133 The significance of right heart catheterization in critically ill patients i

134 cic echocardiography and following up with a right heart catheterization in patients in whom the righ

135 rt the routine use of fluid challenge during right heart catheterization in patients with risk factor

136 phic parameters and hemodynamics obtained by right heart catheterization in PH with AF.

137 failure and may obviate the need for routine right heart catheterization in potential heart transplan

138 e findings support the role of comprehensive right heart catheterization in preprocedural risk strati

139 valence of exercise-induced PH determined by right heart catheterization in scleroderma spectrum diso

140 cteristics of echocardiography compared with right heart catheterization in the determination of syst

141 ulmonary artery pressure (mPAP) diagnosed by right heart catheterization in the U.S. Veterans Affairs

142 We studied 233 patients assigned to right heart catheterization in the Vasodilation in the M

143 66.4 [9.9] years; 3.3% female) who underwent right heart catheterization in this cohort study, Td and

144 diography were performed simultaneously with right-heart catheterization in 51 consecutive patients (

145 se and pulmonary hypertension (documented by right heart catheterization) in a multicenter, randomize

146 ts were more than 15000 adults who underwent right heart catheterization, including 12232 in the Vete

147 l database, RSW was superior to conventional right heart catheterization indices at assessing risk of

148 They also underwent right-heart catheterization, intra-aortic balloon pumpin

149 Invasive exercise right heart catheterization is a gold standard in diagno

150 Exercise right heart catheterization is considered the gold stand

151 Fluid challenge at the time of right heart catheterization is easily performed, safe, a

152 In conclusion, right heart catheterization is necessary to confirm POPH

153 However, performing exercise during right heart catheterization is not universally available

154 Right heart catheterization is the gold standard for ass

155 Cardiac output measurement via right heart catheterization is used extensively for hemo

156 A total of 469 CA patients underwent right heart catheterization (light chain CA=42% and tran

157 n (PAH), acute vasoreactivity testing during right heart catheterization may identify acute vasorespo

158 Twenty patients with PH underwent right heart catheterization: mean pulmonary artery press

159 Right heart catheterization measured pulmonary capillary

160 Pericardial tamponade was suggested by right heart catheterization measurements and diagnosed b

161 ecutive heart transplant recipients analyzed right heart catheterization measurements, inotrope score

162 Using right heart catheterization measurements, mild PH was de

163 operative transthoracic echocardiography and right heart catheterization measurements.

164 ents (simultaneously measured mPAP) and with right heart catheterization measurements.

165 iology, patient demographic characteristics, right heart catheterization, mechanical circulatory supp

166 Among patients with right heart catheterization (n=61), PH was present in 51

167 study patients were divided into 2 groups by right heart catheterization: no PH (mean pulmonary arter

168 t of hemodynamic parameters obtained through right heart catheterization on patient-centered outcomes

169 ailure (OR, 3.7 [95% CI, 3.1-4.4]) and prior right heart catheterization (OR, 3.8 [95% CI, 3.4-4.3]).

170 t mouse models of pertussis by Fulton index, right heart catheterization, or Doppler echocardiogram.

171 PCWP (right heart catheterization), oxygen uptake (breath x br

172 ury during interventional procedures such as right heart catheterization, pacemaker implantation, inv

173 Doppler assessment of transvalvular flow and right heart catheterization performed during pacing at A

174 Right heart catheterization plays a pivotal role in the

175 Invasive hemodynamic evaluation through right heart catheterization plays an essential role in t

176 ved in the PVDOMICS study, the comprehensive right heart catheterization protocol described here hold

177 progress in echocardiography and biomarkers, right heart catheterization remains the only test that c

178 ldren diagnosed with PHT, who underwent both right heart catheterization (RHC) and CT, were enrolled

179 Correlation with same-day right heart catheterization (RHC) and scan-rescan repeat

180 57 patients with normal mPAP) who underwent right heart catheterization (RHC) and three-directional

181 Analysis of data from right heart catheterization (RHC) and transthoracic echo

182 and pulmonary hypertension (PH) diagnosed by right heart catheterization (RHC) are independent risk f

183 fic transthoracic echocardiography (TTE) and right heart catheterization (RHC) data was used to ident

184 Right heart catheterization (RHC) is commonly performed

185 Right heart catheterization (RHC) is commonly used in th

186 Right heart catheterization (RHC) must be performed in p

187 Right heart catheterization (RHC) plays a pivotal role a

188 hen followed for the outcome of undergoing a right heart catheterization (RHC) used as a surrogate ma

189 psy-proven sarcoidosis and SAPH confirmed by right heart catheterization (RHC) were identified from 1

190 6-min-walk testing, V/Q scanning, CTPA, and right heart catheterization (RHC) were prospectively obt

191 Suspected HF patients underwent right heart catheterization (RHC), CMR and transthoracic

192 ure (mPAP) value of at least 25 mm Hg during right heart catheterization (RHC).

193 ansplant patients are followed with periodic right heart catheterizations (RHCs) to identify post-tra

194 We suggest that right heart catheterization should be reserved for patie

195 Right heart catheterization showed severe precapillary P

196 e anesthetized rat with a recently developed right-heart catheterization technique.

197 ations of variables collected during resting right heart catheterization that best predicted abnormal

198 ients with advanced heart failure undergoing right heart catheterization to assess cardiac transplant

199 sthoracic echocardiography further underwent right heart catheterization to confirm the diagnosis of

200 Subjects underwent right heart catheterization to define LV pressure-volume

201 went invasive haemodynamic measurements with right heart catheterization to define Starling and left

202 Sixty healthy subjects underwent right heart catheterization to measure age- and sex-rela

203 Right heart catheterization using exercise stress is the

204 Left and right heart catheterization using MR guidance is feasibl

205 ditional baseline characteristics, including right heart catheterization variables, were not consiste

206 Diagnosis was confirmed by right heart catheterization, ventilation-perfusion lung

207 ed to medical therapy with a sham procedure (right heart catheterization) versus medical therapy and

208 The confirmed PAH prevalence on right heart catheterization was 2.1% (95% confidence int

209 in beta-thalassemia patients as confirmed on right heart catheterization was 2.1%, with an approximat

210 The PCWP obtained from right heart catheterization was compared with diastolic

211 Right heart catheterization was employed in one study to

212 Right heart catheterization was performed and serum uric

213 Right heart catheterization was performed before and aft

214 Right heart catheterization was performed immediately af

215 Left and right heart catheterization was performed in 7 swine wit

216 To investigate this hypothesis, right heart catheterization was performed in eight males

217 0.55 T (<1 degrees C heating) and MRI-guided right heart catheterization was performed in seven study

218 Right heart catheterization was performed using a pressu

219 identified 12 (71%) of 19 patients for whom right heart catheterization was unnecessary.

220 Using right-heart catheterization, we evaluated the acute pulm

221 ight chain-CA or transthyretin CA undergoing right heart catheterization were analyzed.

222 h severe aortic stenosis and a preprocedural right heart catheterization were assessed.

223 s with PAH or ILD-associated PH confirmed by right heart catheterization were included in the study.

224 4, treadmill testing, echocardiography, and right heart catheterization were performed.

225 Echocardiography and right heart catheterization were performed.

226 hods Individuals scheduled for a left and/or right heart catheterization were prospectively enrolled

227 Simultaneous echocardiography and right heart catheterization were prospectively performed

228 resistance (PVR) > 400 dyn s cm(-5) based on right heart catheterization were randomized to treatment

229 ing transient RBBB pattern in lead V1 during right heart catheterization were studied.

230 ds: Adult patients with PAH with two or more right heart catheterizations were identified from a mult

231 ams (at 1, 2, 3, 4, 6, 9, and 12 months) and right heart catheterizations were performed after LVAD i

232 us Doppler echocardiographic examination and right-heart catheterization were performed in 44 patient

233 and left ventricular (LV) filling pressures (right heart catheterization) were measured under varying

234 ients who underwent 4D flow MRI and invasive right heart catheterization with a shunt run between Aug

235 FpEF, all patients who received a diagnostic right heart catheterization with PCWP-measurements at re

236 Right-heart catheterization, with its associated disadva

237 clinic with transthoracic echocardiogram and right heart catheterization within 1 year.

238 All subjects with hemodynamics measured by right heart catheterization within 30 days before left v

239 ke on SPECT myocardial perfusion imaging and right heart catheterization within 4 wk were studied pro

240 e hypothesized that a fluid challenge during right heart catheterization would identify occult pulmon